Infliximab IBD Influenza Vaccine Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01666535
Recruitment Status : Completed
First Posted : August 16, 2012
Last Update Posted : May 9, 2016
Janssen Inc.
Information provided by (Responsible Party):
Jennifer deBruyn, University of Calgary

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : March 2013
  Actual Study Completion Date : August 2013